While antibody-based immunohistochemistry approaches targeting a couple of Tau modifications have contributed significantly to understanding the Tau distribution and the appearance of tangles [6, 19, 20], it is not known if the molecular mechanisms of Tau aggregation are the same as in humans, where we observe an ordered accumulation of PTMs as AD progresses. Here, MAPT is linked to Alzheimer disease.